entinostat has been researched along with Cancer of Esophagus in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to evaluate the anticancer effects of MS-275 combined with DDP on ESCC cell line EC9706 both in vitro and in vivo, and to investigate the possible mechanisms that mediate these effects." | 1.56 | MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells. ( Cui, Y; Guan, F; Li, Y; Li, Z; Liu, H; Liu, T; Ma, S; Wang, Y; Zhang, Y; Zhang, Z, 2020) |
| "Esophageal squamous cell carcinoma (ESCC) is a malignant tumor with low survival rate, so new therapies are urgently needed." | 1.51 | Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. ( Cui, Y; Guan, F; Huang, T; Li, P; Liu, H; Liu, T; Ma, S; Wang, Y; Xu, L; Zang, X; Zhang, Y; Zhou, J; Zhou, X, 2019) |
| "Esophageal cancers are highly aggressive tumors with poor prognosis despite some recent advances in surgical and radiochemotherapy treatment options." | 1.42 | Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. ( Ahrens, TD; Boerries, M; Busch, H; Follo, M; Hembach, S; Hoeppner, J; Hopt, UT; Lassmann, S; Ostendorp, J; Timme, S; Werner, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, T | 2 |
| Guan, F | 2 |
| Wang, Y | 4 |
| Zhang, Z | 1 |
| Li, Y | 1 |
| Cui, Y | 2 |
| Li, Z | 1 |
| Liu, H | 2 |
| Zhang, Y | 2 |
| Ma, S | 2 |
| Huang, XP | 1 |
| Li, X | 1 |
| Situ, MY | 1 |
| Huang, LY | 1 |
| Wang, JY | 1 |
| He, TC | 1 |
| Yan, QH | 1 |
| Xie, XY | 1 |
| Zhang, YJ | 1 |
| Gao, YH | 1 |
| Li, YH | 1 |
| Rong, TH | 1 |
| Wang, MR | 1 |
| Cai, QQ | 1 |
| Fu, JH | 1 |
| Feingold, PL | 1 |
| Surman, DR | 1 |
| Brown, K | 1 |
| Xu, Y | 1 |
| McDuffie, LA | 1 |
| Shukla, V | 1 |
| Reardon, ES | 1 |
| Crooks, DR | 1 |
| Trepel, JB | 1 |
| Lee, S | 1 |
| Lee, MJ | 1 |
| Gao, S | 1 |
| Xi, S | 1 |
| McLoughlin, KC | 1 |
| Diggs, LP | 1 |
| Beer, DG | 1 |
| Nancarrow, DJ | 1 |
| Neckers, LM | 1 |
| Davis, JL | 1 |
| Hoang, CD | 1 |
| Hernandez, JM | 1 |
| Schrump, DS | 1 |
| Ripley, RT | 1 |
| Xu, L | 1 |
| Zhou, J | 1 |
| Huang, T | 1 |
| Li, P | 1 |
| Zhou, X | 1 |
| Zang, X | 1 |
| Ahrens, TD | 1 |
| Timme, S | 1 |
| Hoeppner, J | 1 |
| Ostendorp, J | 1 |
| Hembach, S | 1 |
| Follo, M | 1 |
| Hopt, UT | 1 |
| Werner, M | 1 |
| Busch, H | 1 |
| Boerries, M | 1 |
| Lassmann, S | 1 |
5 other studies available for entinostat and Cancer of Esophagus
| Article | Year |
|---|---|
MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Benzamides; Cell Line | 2020 |
Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transport | 2018 |
Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carr | 2018 |
Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Cycle Checkpoi | 2019 |
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Topics: Acetylation; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; | 2015 |